Calling the National Cancer Institute
WASHINGTON--Up to one-third of callers to the National Cancer Institute’s hot line for cancer information(1-800-4-CANCER) get a busy signal or hang up because of the long wait for someone to pick up, according to a report by the inspector general of the Department of Health and Human Services.
WASHINGTON--Up to one-third of callers to the National Cancer Institutes hot line for cancer information(1-800-4-CANCER) get a busy signal or hang up because of the long wait for someone to pick up, according to a report by the inspector general of the Department of Health and Human Services.
The wait can be as long as 20 minutes. This year it is averaging 5.3 minutes, down from an average of 7.2 minutes last year, said Cristy Thomsen, chief of the NCIs Cancer Information Service. Ms. Thomsen agreed to many of the inspector generals recommendations, and said the NCI plans to address the problems.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
